Project Grant HT94252410471
Award Date 8/1/24
Completion Date 7/31/27
Dollars Obligated $601K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Rochester, NY 14611, USA
Similar Awards
- The University of Rochester was awarded a $1,829,300.00 Project Grant from the U.S. Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from August 1, 2024 to July 31, 2027, will support advanced biomedical research focused on "Mechanistic Insight into the Airborne Hazards Exposure-Related Development of Neurological Disorders." As a leading research university, the...
- The University of Rochester was awarded a $6,292,954 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "Monitoring and Mitigation of Neurological Injuries to Optimize Resilience After Repetitive Head Impacts (MONITOR RHI)," supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The grant, with a period...
- This Project Grant award in the amount of $308,000.00 was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Rochester. The grant is funding a research project to investigate "INVESTIGATING MICROGLIAL REMODELING OF NEURAL CIRCUITS IN PREGNANCY" over a 2-year period from November 15, 2023 to November 14, 2025. The project aims to advance scientific understanding of the role of microglia, a type of immune...
- The University of Rochester received a $769,996 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct spinal cord injury research. The 3-year award, which began on September 1, 2024, will support the University of Rochester's investigator-initiated research on spinal cord injuries. Through this federal grant, the university will deliver scientific research and studies to advance medical treatments and care for...
- The University of Rochester received a $812,602 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "IMAGING CANCER MICROENVIRONMENT HOT SPOTS INVOLVED IN PROGRESSION OF MYELODYSPLASTIC SYNDROMES." The research, which will take place from May 2024 to May 2027, aims to improve understanding of the cancer microenvironment and its role in the progression of myelodysplastic syndromes, a group of...
- The University of Rochester was awarded a $660,772 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) for the "ANTICODON-EDITED (ACE) TRNA TREATMENT OF NONSENSE-MEDIATED DUCHENNE MUSCULAR DYSTROPHY" research project. The award has a performance period from August 1, 2025 to July 31, 2029. This grant supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public,...
- The University of Rochester received a $385,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The two-year award, issued on May 1, 2021 and concluding on April 30, 2023, will support the development of UR238, a small-molecule inhibitor of HE4 being investigated for treatment of ovarian cancer. Through this funding, the University of Rochester will conduct research towards transforming...
- The University of Rochester will receive $1,501,044 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program to investigate whether improvement of sleep and lymphatic function can reduce the risk of developing Alzheimer's disease-related dementia after traumatic brain injury. Specifically, the University of Rochester will conduct research from July 1, 2022 to June 30, 2025 to transform military and public health through...
- The University of Rochester was awarded a $1,173,575 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct research on "Anticodon-Edited (ACE) tRNA Treatment of Nonsense-Mediated Duchenne Muscular Dystrophy". The award is for the period of August 1, 2025 to July 31, 2029. The Military Medical Research and Development program supports advanced biomedical research initiatives that aim to transform healthcare for military...
- This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program provides $154,000.00 to the University of Rochester to conduct research on NETRIN-1 as a druggable driver of pancreatic neuroendocrine tumor metastasis. The project will run from November 1, 2024 to October 31, 2025. As a leading research university with extensive federal research capabilities, the University of Rochester will leverage its expertise...